Current trends in the real life use of Dalbavancin: report of a study panel.
Sign Up to like & getrecommendations! Published in 2020 at "International journal of antimicrobial agents"
DOI: 10.1016/j.ijantimicag.2020.106107
Abstract: Dalbavancin is a novel lipoglycopeptide antibiotic, with a chemical structure similar to teicoplanin. Dalbavancin is approved and marketed since 2014 in the USA and 2015 in the EU for the treatment of acute bacterial skin… read more here.
Keywords: real life; current trends; use; use dalbavancin ... See more keywords
Evaluating the Use of Dalbavancin for Off-Label Indications
Sign Up to like & getrecommendations! Published in 2022 at "Infectious Disease Reports"
DOI: 10.3390/idr14020032
Abstract: (1) Background: Dalbavancin is a long-acting lipoglycopeptide antibiotic approved for skin and soft-tissue infections. Post-marketing experience suggests dalbavancin is being used for off-label indications that normally require long-term intravenous (IV) antibiotics; however, data assessing this… read more here.
Keywords: label indications; dalbavancin; use dalbavancin; evaluating use ... See more keywords